Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cefotetan therapy for gonococcal urethritis and cervicitis.

R Z Youssef1, M Murray, B Holmes

  • 1Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana 70112.

Sexually Transmitted Diseases
|April 1, 1990
PubMed
Summary

Cefotetan demonstrates safety and efficacy in treating gonorrhea. This antibiotic effectively cleared Neisseria gonorrhoeae infections in patients, with minimal adverse effects observed during the study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Therapeutic potential of targeting IRES-dependent c-myc translation in multiple myeloma cells during ER stress.

Oncogene·2023
Same author

A technique for retrieving misplaced intramedullary metalwork during total knee replacement.

Annals of the Royal College of Surgeons of England·2019
Same author

mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.

Oncogene·2017
Same author

Therapeutic potential of targeting IRES-dependent c-myc translation in multiple myeloma cells during ER stress.

Oncogene·2015
Same author

Microbial water quality communication: public and practitioner insights from British Columbia, Canada.

Journal of water and health·2014
Same author

The effect of workplace based strengthening on low back injury rates: A case study in the strip mining industry.

Journal of occupational rehabilitation·2013

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Public Health

Background:

  • Neisseria gonorrhoeae infections, commonly known as gonorrhea, represent a significant public health concern.
  • Antimicrobial resistance in Neisseria gonorrhoeae necessitates the evaluation of alternative treatment options.
  • Ceftriaxone is a standard treatment, but its efficacy and safety profile require ongoing comparison with newer agents.

Purpose of the Study:

  • To compare the safety and efficacy of two dosages of cefotetan (0.5 g and 1.0 g) against ceftriaxone (0.25 g) for treating uncomplicated gonorrhea.
  • To assess the microbiological cure rates and symptom resolution following cefotetan and ceftriaxone treatment.
  • To evaluate the tolerability and adverse experiences associated with cefotetan therapy.

Main Methods:

Related Experiment Videos

  • A 3:3:2 randomized trial involving 172 patients with acute gonococcal urethritis or cervicitis.
  • 123 patients were evaluable for treatment outcomes.
  • Microbiological cultures for Neisseria gonorrhoeae were performed at baseline and 4-8 day follow-up.

Main Results:

  • Microbiological cure rates were high for all treatment groups, with only one failure in each cefotetan dosage group.
  • Symptom resolution occurred within 12-72 hours across all treatment arms.
  • Cefotetan was well tolerated, with a low incidence of reported adverse experiences.

Conclusions:

  • Cefotetan, at both 0.5 g and 1.0 g dosages, is considered a safe and effective treatment for uncomplicated gonorrhea.
  • The study supports cefotetan as a viable alternative therapeutic option for gonorrhea treatment.
  • Further research may explore optimal dosing and long-term efficacy of cefotetan.